
The Colen Lab at UPMC Hillman Cancer Center. #Radiomics #Radiogenomics #ImagingCore @UPMCnews @UPMCHillmanCC @PittRadiology
Pittsburgh, PA
Joined October 2019
- Tweets17
- Following49
- Followers46
- Likes24
Colen Lab retweeted
Hot off the press! Our group's new paper "Evolving Role and Translation of Radiomics and Radiogenomics in Adult and Pediatric Neuro-Oncology" at @TheAJNR @PittRadiology #Radiomics #AI #neurooncology
Congrats team! @rrcolen @colen_lab
ajnr.org/content/early/2021/…
Congratulations team! Great work! @drmuratak @PittRadiology @UPMCHillmanCC @ANaingMD @ChristianRolfo
I am happy to share our group`s new #radiomics paper "Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers" @jitcancer
jitc.bmj.com/content/9/4/e00…
@rrcolen @ANaingMD @ChristianRolfo @colen_lab @PittRadiology
#ArtificialIntelligence
Congrats team! @PittRadiology @UPMCHillmanCC
Hot off the press! @JCM_MDPI
MRI-Based Radiomics and Radiogenomics in the Management of Low-Grade Gliomas: Evaluating the Evidence for a Paradigm Shift” @AHabibMD @rrcolen @pascalzinn @colen_lab
mdpi.com/2077-0383/10/7/1411
Colen Lab retweeted
Opening for 4 post-doctoral fellows to work in our Imaging Core @colen_lab at Hillman Cancer Center @UPMC. #fmg #radiology #postdoc @imaging The candidate must have radiology training and will perform tumor measurements such as RECIST, irRC, etc. please email [email protected] – at Pittsburgh, PA
Colen Lab retweeted
Phase II Study of Pembrolizumab in Advanced Rare Cancers Shows Promise cancernetwork.com/article/ph… @ANaingMD @LabNaing @MDAndersonNews
Colen Lab retweeted
While treatment of rare cancers remains a significant challenge, this phase 2 study with Pembrolizumab sheds some light. We thank the patients, caregivers, investigators @MDAndersonNews and collaborators. Thank you @jitcancer for publishing our work.
jitc.bmj.com/content/8/1/e00…
Colen Lab retweeted
ICYMI: A new MD Anderson-led study could lead to a new treatment option for patients with #rarecancers: https://teapawt.net/t.co/K53JGVV76F @ANaingMD #endcancer
Colen Lab retweeted
So happy to be a part of this clinical trial with @ANaingMD @UPMCHillmanCC @UPMCnews – at Pittsburgh, PA
This quoted post is unavailable.
Colen Lab retweeted
A Phase II clinical trial led by our @ANaingMD found #immunotherapy may be effective in some #rarecancers, including squamous cell carcinoma of the skin, carcinoma of unknown primary, adrenocortical carcinoma and paraganglioma-pheochromocytoma: https://teapawt.net/t.co/K53JGWcHYd #endcancer
Colen Lab retweeted
Are #Cancer Patients at Higher Risk of Death with #COVID19? Our late-breaking article @JIPOEditors Free download jipoonline.org/preprintartic…
@Dr_R_Kurzrock @jacobadashek Roy Chemaly @BCMFromtheLabs @TCHResearchNews @MDAndersonNews @MoffittNews @UCSDHealth #immunodeficiency
Awesome and fruitful collaboration @colen_lab @ANaingMD @DavidHongMD @VivekSubbiah on #radiomics to predict response to #pembrolizumab in patients with advance #cancer . @UPMCnews @UPMCnews @UPMCHillmanCC @MDAndersonNews @pascalzinn
This quoted post is unavailable.
Congratulations @pascalzinn! We are now able to image live cells over hours and days!
Live cell fluorescence imaging here we come:)! @PittNeurosurg @NikonUSA @BOrganoid @cancerscnews @UPMCHillmanCC
1
Colen Lab retweeted
New rotating student on service....drawing some complex brain stem nuclei map...perhaps....@PittNeurosurg @rrcolen










